Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP386602.RA4JW03ebmhV3xTB7-JdMqLK9FVpjr3M-eV-Qafdf0lb4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP386602.RA4JW03ebmhV3xTB7-JdMqLK9FVpjr3M-eV-Qafdf0lb4130_assertion type Assertion NP386602.RA4JW03ebmhV3xTB7-JdMqLK9FVpjr3M-eV-Qafdf0lb4130_head.
- NP386602.RA4JW03ebmhV3xTB7-JdMqLK9FVpjr3M-eV-Qafdf0lb4130_assertion description "[Based on the recent identification of TET2 mutations, we evaluated the mutational status of TET1, TET2, and TET3 in myeloproliferative neoplasms (MPNs), chronic myelomonocytic leukemia (CMML), and acute myeloid leukemia (AML).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP386602.RA4JW03ebmhV3xTB7-JdMqLK9FVpjr3M-eV-Qafdf0lb4130_provenance.
- NP386602.RA4JW03ebmhV3xTB7-JdMqLK9FVpjr3M-eV-Qafdf0lb4130_assertion evidence source_evidence_literature NP386602.RA4JW03ebmhV3xTB7-JdMqLK9FVpjr3M-eV-Qafdf0lb4130_provenance.
- NP386602.RA4JW03ebmhV3xTB7-JdMqLK9FVpjr3M-eV-Qafdf0lb4130_assertion SIO_000772 19420352 NP386602.RA4JW03ebmhV3xTB7-JdMqLK9FVpjr3M-eV-Qafdf0lb4130_provenance.
- NP386602.RA4JW03ebmhV3xTB7-JdMqLK9FVpjr3M-eV-Qafdf0lb4130_assertion wasDerivedFrom befree-20140225 NP386602.RA4JW03ebmhV3xTB7-JdMqLK9FVpjr3M-eV-Qafdf0lb4130_provenance.
- NP386602.RA4JW03ebmhV3xTB7-JdMqLK9FVpjr3M-eV-Qafdf0lb4130_assertion wasGeneratedBy ECO_0000203 NP386602.RA4JW03ebmhV3xTB7-JdMqLK9FVpjr3M-eV-Qafdf0lb4130_provenance.